Biphasic modulation of ryanodine binding to sarcoplasmic reticulum vesicles of skeletal muscle by Zn2+ ions

Ruo Hong Xia, Xiao Yang Cheng, Hui Wang, Ke Ying Chen, QingQing Wei, Xiao Hui Zhang, Pei Hong Zhu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

With the use of a [3H]ryanodine binding assay, the modulation of skeletal muscle ryanodine receptor (RyR1) by Zn2+ was investigated. In the presence of 100 μM free Ca2+ concentration ([Ca2+](f)) as activator, the equilibrium [3H]ryanodine binding to heavy sarcoplasmic reticulum vesicles was biphasically modulated by Zn2+. The binding was increased by a free Zn2+ concentration ([Zn2+](f)) of less than 1 μM; a peak binding, approx. 140 of the control (without added Zn2+) was obtained at 0.3 μM [Zn2+](f). An inhibitory effect of Zn2+ became obvious with a [Zn2+](f) of more than 1 μM; the [Zn2+](f) for producing half inhibition was 2.7 ± 0.5 μM (mean ± S.D.). Scatchard analysis indicated that the increase in the binding induced by low [Zn2+](f) was due to a decrease in K(d), whereas both an increase in K(d) and a possible decrease in B(max) were responsible for the decrease in binding induced by high [Zn2+](f). The binding in the presence of micromolar [Zn2+](f) showed a biphasic time course. In the presence of 3 μM [Zn2+](f), after reaching a peak with an increased rate of initial binding, the binding gradually declined. The decline phase could be prevented by decreasing [Zn2+](f) to 0.5 μM or by adding 2 mM dithiothreitol, a thiol-reducing agent. The [Ca2+](f) dependence of binding was changed significantly by Zn2+, whereas Ca2+ had no clear effect on the [Zn2+](f) dependence of binding. Moreover, some interactions were found in the effects between Zn2+ and other RyR1 modulators. It is indicated that Zn2+ can modulate the activation sites and inactivation sites for Ca2+ on RyR1. The physiological significance of the effects of Zn2+ on ryanodine binding is discussed.

Original languageEnglish (US)
Pages (from-to)279-286
Number of pages8
JournalBiochemical Journal
Volume345
Issue number2
DOIs
StatePublished - Jan 15 2000
Externally publishedYes

Fingerprint

Ryanodine
Ryanodine Receptor Calcium Release Channel
Sarcoplasmic Reticulum
Muscle
Skeletal Muscle
Modulation
Ions
Dithiothreitol
Reducing Agents
Sulfhydryl Compounds
Modulators
Assays
Chemical activation

Keywords

  • Binding assay
  • Ca
  • Caffeine
  • Dithiothreitol
  • Ryanodine receptor

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Biphasic modulation of ryanodine binding to sarcoplasmic reticulum vesicles of skeletal muscle by Zn2+ ions. / Xia, Ruo Hong; Cheng, Xiao Yang; Wang, Hui; Chen, Ke Ying; Wei, QingQing; Zhang, Xiao Hui; Zhu, Pei Hong.

In: Biochemical Journal, Vol. 345, No. 2, 15.01.2000, p. 279-286.

Research output: Contribution to journalArticle

Xia, Ruo Hong ; Cheng, Xiao Yang ; Wang, Hui ; Chen, Ke Ying ; Wei, QingQing ; Zhang, Xiao Hui ; Zhu, Pei Hong. / Biphasic modulation of ryanodine binding to sarcoplasmic reticulum vesicles of skeletal muscle by Zn2+ ions. In: Biochemical Journal. 2000 ; Vol. 345, No. 2. pp. 279-286.
@article{6102dd332b8a4ee0918072f6a6777abb,
title = "Biphasic modulation of ryanodine binding to sarcoplasmic reticulum vesicles of skeletal muscle by Zn2+ ions",
abstract = "With the use of a [3H]ryanodine binding assay, the modulation of skeletal muscle ryanodine receptor (RyR1) by Zn2+ was investigated. In the presence of 100 μM free Ca2+ concentration ([Ca2+](f)) as activator, the equilibrium [3H]ryanodine binding to heavy sarcoplasmic reticulum vesicles was biphasically modulated by Zn2+. The binding was increased by a free Zn2+ concentration ([Zn2+](f)) of less than 1 μM; a peak binding, approx. 140 of the control (without added Zn2+) was obtained at 0.3 μM [Zn2+](f). An inhibitory effect of Zn2+ became obvious with a [Zn2+](f) of more than 1 μM; the [Zn2+](f) for producing half inhibition was 2.7 ± 0.5 μM (mean ± S.D.). Scatchard analysis indicated that the increase in the binding induced by low [Zn2+](f) was due to a decrease in K(d), whereas both an increase in K(d) and a possible decrease in B(max) were responsible for the decrease in binding induced by high [Zn2+](f). The binding in the presence of micromolar [Zn2+](f) showed a biphasic time course. In the presence of 3 μM [Zn2+](f), after reaching a peak with an increased rate of initial binding, the binding gradually declined. The decline phase could be prevented by decreasing [Zn2+](f) to 0.5 μM or by adding 2 mM dithiothreitol, a thiol-reducing agent. The [Ca2+](f) dependence of binding was changed significantly by Zn2+, whereas Ca2+ had no clear effect on the [Zn2+](f) dependence of binding. Moreover, some interactions were found in the effects between Zn2+ and other RyR1 modulators. It is indicated that Zn2+ can modulate the activation sites and inactivation sites for Ca2+ on RyR1. The physiological significance of the effects of Zn2+ on ryanodine binding is discussed.",
keywords = "Binding assay, Ca, Caffeine, Dithiothreitol, Ryanodine receptor",
author = "Xia, {Ruo Hong} and Cheng, {Xiao Yang} and Hui Wang and Chen, {Ke Ying} and QingQing Wei and Zhang, {Xiao Hui} and Zhu, {Pei Hong}",
year = "2000",
month = "1",
day = "15",
doi = "10.1042/0264-6021:3450279",
language = "English (US)",
volume = "345",
pages = "279--286",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Biphasic modulation of ryanodine binding to sarcoplasmic reticulum vesicles of skeletal muscle by Zn2+ ions

AU - Xia, Ruo Hong

AU - Cheng, Xiao Yang

AU - Wang, Hui

AU - Chen, Ke Ying

AU - Wei, QingQing

AU - Zhang, Xiao Hui

AU - Zhu, Pei Hong

PY - 2000/1/15

Y1 - 2000/1/15

N2 - With the use of a [3H]ryanodine binding assay, the modulation of skeletal muscle ryanodine receptor (RyR1) by Zn2+ was investigated. In the presence of 100 μM free Ca2+ concentration ([Ca2+](f)) as activator, the equilibrium [3H]ryanodine binding to heavy sarcoplasmic reticulum vesicles was biphasically modulated by Zn2+. The binding was increased by a free Zn2+ concentration ([Zn2+](f)) of less than 1 μM; a peak binding, approx. 140 of the control (without added Zn2+) was obtained at 0.3 μM [Zn2+](f). An inhibitory effect of Zn2+ became obvious with a [Zn2+](f) of more than 1 μM; the [Zn2+](f) for producing half inhibition was 2.7 ± 0.5 μM (mean ± S.D.). Scatchard analysis indicated that the increase in the binding induced by low [Zn2+](f) was due to a decrease in K(d), whereas both an increase in K(d) and a possible decrease in B(max) were responsible for the decrease in binding induced by high [Zn2+](f). The binding in the presence of micromolar [Zn2+](f) showed a biphasic time course. In the presence of 3 μM [Zn2+](f), after reaching a peak with an increased rate of initial binding, the binding gradually declined. The decline phase could be prevented by decreasing [Zn2+](f) to 0.5 μM or by adding 2 mM dithiothreitol, a thiol-reducing agent. The [Ca2+](f) dependence of binding was changed significantly by Zn2+, whereas Ca2+ had no clear effect on the [Zn2+](f) dependence of binding. Moreover, some interactions were found in the effects between Zn2+ and other RyR1 modulators. It is indicated that Zn2+ can modulate the activation sites and inactivation sites for Ca2+ on RyR1. The physiological significance of the effects of Zn2+ on ryanodine binding is discussed.

AB - With the use of a [3H]ryanodine binding assay, the modulation of skeletal muscle ryanodine receptor (RyR1) by Zn2+ was investigated. In the presence of 100 μM free Ca2+ concentration ([Ca2+](f)) as activator, the equilibrium [3H]ryanodine binding to heavy sarcoplasmic reticulum vesicles was biphasically modulated by Zn2+. The binding was increased by a free Zn2+ concentration ([Zn2+](f)) of less than 1 μM; a peak binding, approx. 140 of the control (without added Zn2+) was obtained at 0.3 μM [Zn2+](f). An inhibitory effect of Zn2+ became obvious with a [Zn2+](f) of more than 1 μM; the [Zn2+](f) for producing half inhibition was 2.7 ± 0.5 μM (mean ± S.D.). Scatchard analysis indicated that the increase in the binding induced by low [Zn2+](f) was due to a decrease in K(d), whereas both an increase in K(d) and a possible decrease in B(max) were responsible for the decrease in binding induced by high [Zn2+](f). The binding in the presence of micromolar [Zn2+](f) showed a biphasic time course. In the presence of 3 μM [Zn2+](f), after reaching a peak with an increased rate of initial binding, the binding gradually declined. The decline phase could be prevented by decreasing [Zn2+](f) to 0.5 μM or by adding 2 mM dithiothreitol, a thiol-reducing agent. The [Ca2+](f) dependence of binding was changed significantly by Zn2+, whereas Ca2+ had no clear effect on the [Zn2+](f) dependence of binding. Moreover, some interactions were found in the effects between Zn2+ and other RyR1 modulators. It is indicated that Zn2+ can modulate the activation sites and inactivation sites for Ca2+ on RyR1. The physiological significance of the effects of Zn2+ on ryanodine binding is discussed.

KW - Binding assay

KW - Ca

KW - Caffeine

KW - Dithiothreitol

KW - Ryanodine receptor

UR - http://www.scopus.com/inward/record.url?scp=0034650357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034650357&partnerID=8YFLogxK

U2 - 10.1042/0264-6021:3450279

DO - 10.1042/0264-6021:3450279

M3 - Article

VL - 345

SP - 279

EP - 286

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -